Overview:
Expert craftsmanship ensures precision and comfort in dental and medical procedures with the Miltex Self-Aspirating Syringe 1.8cc. This syringe features a self-aspirating mechanism that ensures accurate and controlled administration of anesthesia, enhancing safety and effectiveness. The 1.8cc capacity makes it ideal for a wide range of applications, providing reliable performance with every use.
Specifications:
-
Volume: 1.8cc
-
Material: Made from high-quality, lightweight stainless steel
-
Design: Features a blunt harpoon rod that facilitates aspiration through counter pressure, enhancing safety and control during use.
-
Grip: Equipped with a thumb control ring style and palm pad wing grip for better handling and comfort.
-
Usage: Ideal for delivering local anesthetics in dental applications.
Key Features:
-
Lightweight Construction: The syringe's design reduces hand fatigue during prolonged use, ensuring the user's comfort.
-
Blunt Harpoon Rod: Allows for safe aspiration through counter pressure, minimizing the risk of needle stick injuries.
-
Thumb Control Ring: Provides superior control and precision during dental procedures.
-
Sterility: We individually package each syringe to maintain sterility until use.
Applications:
Dental professionals widely use this syringe for administering local anesthetics because it is reliable and easy to use.
Manufacturer:
Integra LifeSciences Holdings Corporation is a leading global medical technology company specializing in the development and manufacturing of medical devices and tissue products for various surgical applications. The company focuses on innovative solutions for neurosurgery, reconstructive surgery, and general surgery.
Key Details:
- Founded: 1989
-
Headquarters: Princeton, New Jersey, USA
-
CEO: Peter Arduini
-
Employees: Over 3,000 globally
-
Stock: Traded on NASDAQ under the ticker symbol IART
Business Focus:
Integra LifeSciences provides a broad portfolio of products and solutions across multiple medical disciplines:
-
Neurosurgery: Devices, instruments, and systems used in neurosurgery, neuromonitoring, neurotrauma, and critical care.
-
Reconstructive Surgery: Tissue products used for acute wound care, burn treatment, chronic wound management, hernia repair, and peripheral nerve protection and repair.
-
General Surgery: Solutions that simplify procedures and enhance patient outcomes.
Innovations and Acquisitions:
Integra LifeSciences has grown through strategic acquisitions and innovations:
-
Acquired TEI Biosciences and TEI Medical in 2015: Expanded their product line to include dermal repair scaffolding products.
-
Acquired Derma Sciences in 2017: Enhanced their wound care offerings with products like the TCC-EZ for diabetic foot ulcers.
-
Acquired Johnson & Johnson’s Codman Neurosurgery business in 2017: Strengthened their position in the neurosurgery market.
-
Acquired ACell in 2021: Expanded their capabilities in regenerative medicine.
Corporate Responsibility:
Integra LifeSciences is committed to reducing uncertainty for surgeons through the provision of dependable and inventive products. To create better products and procedures, the company involves surgeons in the development process. They focus on delivering their products promptly and ensuring they meet the highest standards of quality and safety.
For more detailed information, you can visit Integra LifeSciences' official website and their Investor Relations page? (Wikipedia)?? (Integra LifeSci)?? (Integra LifeSci)?.
